AngioDynamics Inc. (NASDAQ: ANGO) Q3 2023 earnings call dated Mar. 30, 2023 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
AngioDynamics Inc.
-(ANGO)
XNAS:ANGO
ANGO Earnings: AngioDynamics reports loss for Q3; revenue up 9%
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported a wider loss for the third quarter when the medical device maker's revenues increased by
Why AngioDynamics (ANGO) deserves a place on investors’ watchlist
The market reopening has created a conducive atmosphere to carry out elective medical procedures which were deferred on a large scale during
ANGO Earnings: AngioDynamics Q1 loss widens. Revenue up 6%
AngioDynamics Inc. (NASDAQ: ANGO) on Friday reported a wider loss for the first quarter of 2023, despite a modest increase in revenues.
Angiodynamics Inc (ANGO) Q1 2023 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q1 2023 earnings call dated Oct. 06, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Angiodynamics Inc (ANGO) Q4 2022 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q4 2022 earnings call dated Jul. 12, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
ANGO Earnings: AngioDynamics swings to profit in Q4; revenues beat estimates
AngioDynamics Inc. (NASDAQ: ANGO) on Tuesday reported a modest profit for the fourth quarter of 2022 compared to breakeven last year. Revenues
ANGO Stock: Is it the right time to invest in AngioDynamics now?
The performance of AngioDynamics, Inc. (NASDAQ: ANGO) has not been very impressive lately, despite being part of a rapidly growing industry. But
AngioDynamics Inc (ANGO) Q3 2022 Earnings Call Transcript
AngioDynamics Inc (NASDAQ:ANGO) Q3 2022 Earnings Call dated Apr. 07, 2022. Coporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A. Trowbridge -- Executive
AngioDynamics (ANGO) Q3 earnings beat estimates as sales increase
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported higher earnings for the third quarter of 2022 when the medical device maker's net sales
Angiodynamics Inc (ANGO) Q2 2022 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q2 2022 earnings call dated Jan. 06, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer
Angiodynamics Inc (ANGO) Q1 2022 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q1 2022 earnings call dated Sep. 30, 2021. Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Angiodynamics Inc (ANGO) Q4 2021 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q4 2021 earnings call dated Jul. 13, 2021 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Earnings calendar for the week of July 12
Technology stocks took a beating from the government’s decision to restore net neutrality and weighed on the benchmark indexes mid-week. But, the
AngioDynamics Inc (ANGO) Q3 2021 Earnings Call
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2021 earnings call dated Mar. 30, 2021. Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. Trowbridge — Executive Vice
AngioDynamics Inc (ANGO) Q3 2021 Earnings Call Transcript
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2021 earnings call dated Mar. 30, 2021. Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A. Trowbridge -- Executive
Earnings calendar for the week of March 29
Encouraging data from the labor market and optimism brought on by the stimulus package bolstered stock markets this week. Benchmark indexes Dow
AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive Vice
AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call Transcript
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive
AngioDynamics Inc. (ANGO) Q1 2021 Earnings Call Transcript
AngioDynamics Inc. (NASDAQ: ANGO) Q1 2021 earnings call dated Sep. 29, 2020 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Key highlights from AngioDynamics (ANGO) Q1 2021 earnings results
AngioDynamics Inc. (NASDAQ: ANGO) reported first quarter 2021 earnings results today. Net sales increased 6.3% to $70.2 million but were impacted by